Neurontin is a brand name of gabapentin, approved by the FDA in the following formulation(s):
NEURONTIN (gabapentin - capsule; oral)
Manufacturer: PFIZER PHARMS
Approval date: December 30, 1993
Strength(s): 100MG [AB], 300MG [AB], 400MG [RLD][AB]
NEURONTIN (gabapentin - solution; oral)
Manufacturer: PARKE DAVIS
Approval date: March 2, 2000
Strength(s): 250MG/5ML [RLD][AA]
NEURONTIN (gabapentin - tablet; oral)
Manufacturer: PFIZER PHARMS
Approval date: October 9, 1998
Strength(s): 600MG [AB], 800MG [RLD][AB]
Has a generic version of Neurontin been approved?
A generic version of Neurontin has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Neurontin and have been approved by the FDA:
gabapentin capsule; oral
Manufacturer: ACTAVIS ELIZABETH
Approval date: September 12, 2003
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: ALKEM
Approval date: December 17, 2010
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: AMNEAL PHARMS NY
Approval date: July 25, 2007
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: APOTEX INC
Approval date: April 6, 2005
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: AUROBINDO PHARM
Approval date: January 31, 2008
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: HIKMA
Approval date: September 25, 2007
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: INVAGEN PHARMS
Approval date: December 30, 2009
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: MARKSANS PHARMA
Approval date: July 21, 2011
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: MYLAN
Approval date: February 14, 2011
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: RANBAXY
Approval date: October 7, 2005
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: SUN PHARM INDS LTD
Approval date: August 24, 2006
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: TEVA PHARMS
Approval date: October 8, 2004
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
Manufacturer: WATSON LABS
Approval date: May 11, 2007
Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]
gabapentin solution; oral
Manufacturer: HI TECH PHARMA
Approval date: February 18, 2011
Strength(s): 250MG/5ML [AA]
gabapentin tablet; oral
Manufacturer: ACTAVIS ELIZABETH
Approval date: October 21, 2004
Strength(s): 600MG [AB], 800MG [AB]
Manufacturer: APOTEX INC
Approval date: September 13, 2006
Strength(s): 600MG [AB], 800MG [AB]
Manufacturer: AUROBINDO PHARMA LTD
Approval date: October 6, 2011
Strength(s): 600MG [AB], 800MG [AB]
Manufacturer: GLENMARK GENERICS
Approval date: August 18, 2006
Strength(s): 600MG [AB], 800MG [AB]
Manufacturer: HIKMA PHARMS
Approval date: July 21, 2011
Strength(s): 600MG [AB], 800MG [AB]
Manufacturer: IVAX SUB TEVA PHARMS
Approval date: April 29, 2005
Strength(s): 600MG [AB], 800MG [AB]
Manufacturer: MATRIX LABS LTD
Approval date: June 1, 2010
Strength(s): 600MG [AB], 800MG [AB]
Manufacturer: SUN PHARM INDS LTD
Approval date: August 24, 2006
Strength(s): 600MG [AB], 800MG [AB]
Manufacturer: ZYDUS PHARMS USA INC
Approval date: February 11, 2011
Strength(s): 600MG [AB], 800MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Neurontin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Lactam-free amino acids
Patent 6,054,482
Issued: April 25, 2000
Inventor(s): Augart; Helmut & Gebhardt; Uwe & Herrmann; Wolfgang
Assignee(s): Godecke Aktiengesellschaft
The present invention concerns cyclic amino acids of formula ##STR1## substantially free from the lactam ##STR2## wherein n is an integer of from 4 to 6, a process for the preparation thereof, compositions containing the compounds and methods of using them.Patent expiration dates:
- April 25, 2017
- October 25, 2017✓
- April 25, 2017
Liquid pharmaceutical compositions
Patent 7,256,216
Issued: August 14, 2007
Inventor(s): Kulkarni; Neema M. & Schneider; Michael & Silbering; Steven B. & Meyer-Wonnay; Hans & Sanii-Yahyai; Nahid
Assignee(s): Warner-Lambert Company LLC
A liquid pharmaceutical composition of a GABA analog comprising at least one polyhydric alcohol containing 2 to 6 carbon atoms having a pH of about 5.5 to about 7.0 and additionally a two-component liquid pharmaceutical composition comprising a first component comprising a powder mixture comprising a GABA analog and a solid polyhydric alcohol, and a second component comprising a liquid base are described, as well as methods to prepare the compositions and a method for treating cerebral diseases, including epilepsy, faintness attacks, hypokinesia and cranial traumas, neurodegenerative disorders, depression, mania and bipolar disorders, anxiety, panic, inflammation, renal colic, insomnia, gastrointestinal damage, incontinence, pain, including neuropathic pain, muscular pain, skeletal pain, and migraine using a therapeutically effective amount of the pharmaceutical compositions.Patent expiration dates:
- May 28, 2022✓
- November 28, 2022✓
- May 28, 2022
See also...
- Neurontin Consumer Information (Drugs.com)
- Neurontin Consumer Information (Wolters Kluwer)
- Neurontin Capsules Consumer Information (Wolters Kluwer)
- Neurontin Solution Consumer Information (Wolters Kluwer)
- Neurontin Consumer Information (Cerner Multum)
- Neurontin Advanced Consumer Information (Micromedex)
- Neurontin AHFS DI Monographs (ASHP)
- Gabapentin Consumer Information (Drugs.com)
- Gabapentin Consumer Information (Wolters Kluwer)
- Gabapentin Capsules Consumer Information (Wolters Kluwer)
- Gabapentin Enacarbil Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Gabapentin Solution Consumer Information (Wolters Kluwer)
- Gabapentin Consumer Information (Cerner Multum)
- FusePaq Fanatrex Advanced Consumer Information (Micromedex)
- Gabapentin Advanced Consumer Information (Micromedex)
- Gabapentin AHFS DI Monographs (ASHP)
No comments:
Post a Comment